Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand



Status:Completed
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - 80
Updated:8/23/2017
Start Date:September 2003
End Date:August 2017

Use our guide to learn which trials are right for you!

An Outcome Study of Rheumatoid Hand Arthroplasty

A procedure called silicone metacarpophalangeal joint arthroplasty (SMPA) is sometimes used
to treat knuckle deformity in the hands of rheumatoid arthritis (RA) patients. The purpose of
this study is to compare the health outcomes of RA patients who choose to undergo SMPA
surgery to RA patients who do not undergo surgery.

The purpose of this study is to provide a better understanding of the effectiveness of SMPA,
a procedure to correct knuckle deformity in the hands of rheumatoid arthritis patients. This
study will examine whether rheumatoid arthritis patients who undergo SMPA will have better
outcomes than those patients who do not have this surgery.

RA affects 2.1 million Americans and costs the United States an estimated $8.7 billion
annually in medical costs and wages. RA is a progressive disease, and approximately 25% of RA
patients experience hand deformities associated with the destruction of the
metacarpophalangeal (MCP) joints. For the past 30 years, SMPA has been performed on such
patients to correct metacarpophalangeal joint deformity in the rheumatoid hand. SMPA can
provide pain relief, restoration of function, and aesthetic improvement to the patient.
However, because data are limited on its efficacy, SMPA remains a controversial procedure.
Hand surgeons and rheumatologists frequently disagree about the indications for this
procedure and its value to their patients. In addition, most published studies have been
hampered by inadequate consideration of research design, small sample size, and inconsistent
outcome measures. The purpose of this study is to measure short- and long-term outcomes
following SMPA. The study will also define indications of the surgery for specific patient
groups and disease severity. The experiences of both surgery and rheumatology services will
be used to jointly evaluate this surgical procedure.

This study is a multicenter, international outcomes study to evaluate RA patients with severe
MCP joint problems. Patients will choose to be enrolled into a surgical group undergoing SMPA
or a nonsurgical group. Patients will be evaluated at Month 6 and annually until the third
year. Patient evaluations will be based on the Michigan Hand Outcomes Questionnaire, the
Arthritis Impact Measurement Scales questionnaire, and standard, objective hand function
tests.

Inclusion Criteria:

- Diagnosis of rheumatoid arthritis based on the diagnostic criteria of the American
Rheumatology Association

- Able to complete questionnaires in English

- Sum of average metacarpophalangeal joint ulnar drift AND average metacarpophalangeal
joint extensor lag of 50 degrees or greater

Exclusion Criteria:

- Severe medical condition precluding surgery

- Concomitant extensor tendon ruptures and metacarpophalangeal joint disease

- Other joint injury of the hand (e.g., swan-neck deformity, boutonniere deformity)
requiring surgery

- Previous metacarpophalangeal joint replacement on their study hand

- Disease modifying antirheumatic drugs (DMARDs) within the 3 months prior to study
entry
We found this trial at
3
sites
?
mi
from
Derby,
Click here to add this to my saved trials
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Baltimore, Maryland 21218
?
mi
from
Baltimore, MD
Click here to add this to my saved trials